A carregar...

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data

INTRODUCTION: Concizumab enhances thrombin generation (TG) potential in haemophilia patients by inhibiting tissue factor pathway inhibitor (TFPI). In EXPLORER3 (phase 1b), a dose‐dependent pharmacokinetic/pharmacodynamic (PK/PD) relationship was confirmed between concizumab dose, free TFPI and TG po...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haemophilia
Main Authors: Eichler, Hermann, Angchaisuksiri, Pantep, Kavakli, Kaan, Knoebl, Paul, Windyga, Jerzy, Jiménez‐Yuste, Victor, Harder Delff, Philip, Chowdary, Pratima
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379180/
https://ncbi.nlm.nih.gov/pubmed/30408848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.13627
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!